Clinical Trial Results:
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to
Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and
Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular
Systolic Dysfunction and Anemia.
Summary
|
|
EudraCT number |
2005-005278-59 |
Trial protocol |
GB IE LT SK BE EE FI HU DK DE CZ ES SE AT PT NL LV IT BG |
Global completion date |
11 Oct 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Nov 2016
|
First version publication date |
02 Nov 2016
|
Other versions |
|
Summary report(s) |
CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.